{"abstract":"This notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR part 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services (HHS), is contemplating the grant of an exclusive license to practice the inventions embodied in the following Patent Applications to Dimension Therapeutics, Inc. (\"Dimension\") located in Cambridge, Massachusetts, USA:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2016/05/24/2016-12168.html","cfr_references":[],"citation":"81 FR 32762","comment_url":null,"comments_close_on":"2016-06-08","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before June 8, 2016 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2016-12168","effective_on":null,"end_page":32763,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2016/05/24/2016-12168.xml","html_url":"https://www.federalregister.gov/documents/2016/05/24/2016-12168/prospective-grant-of-exclusive-patent-license-development-of-adeno-associated-virus-vectors-for-the","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2016-12168?publication_date=2016-05-24","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2016-05-24/2016-12168/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":128,"last_updated":"2026-06-27 12:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2016-05-24/pdf/2016-12168.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2016-12168.pdf?1464007605","publication_date":"2016-05-24","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2016/05/24/2016-12168.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T07:01:22Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":32762,"subtype":null,"title":"Prospective Grant of Exclusive Patent License: Development of Adeno-Associated Virus Vectors for the Treatment of Glycogen Storage Disease Type Ia","toc_doc":"Development of Adeno-Associated Virus Vectors for the Treatment of Glycogen Storage Disease Type Ia","toc_subject":"Grants of Exclusive Patent Licenses:","topics":[],"type":"Notice","volume":81}